Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Rare Genetic Cause of Erythrodermic Ichthyosis: Chanarin-Dorfman Syndrome.

Indian dermatology online journal·2026
Same author

Sharing a whole-/total-body [<sup>18</sup>F]FDG-PET/CT dataset with CT-derived segmentations: an ENHANCE.PET initiative.

Scientific data·2026
Same author

Is psoriatic arthritis a dissemination of cutaneous psoriatic TRM cells? Role of tissue-resident memory T cells (TRM) in psoriatic disease.

Current opinion in immunology·2025
Same author

Advances in treatment of psoriatic arthritis: current guidelines and emerging therapies.

Current opinion in immunology·2025
Same author

Checkpoint agonists - immunoregulatory role and its implications in the treatment of psoriasis and psoriatic arthritis.

Current opinion in immunology·2025
Same author

Sharing a whole-/total-body [18F]FDG-PET/CT dataset with CT-derived segmentations: an ENHANCE.PET initiative.

Research square·2025

Related Experiment Video

Updated: May 24, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

A cutting edge overview: psoriatic disease.

Siba P Raychaudhuri1

  • 1Department of Medicine, VA Sacramento Medical Centre, 10535 Hospital Way, Mather, CA 95655, USA. sraychaudhuri@ucdavis.edu

Clinical Reviews in Allergy & Immunology
|February 24, 2012
PubMed
Summary
This summary is machine-generated.

Psoriasis and psoriatic arthritis involve complex immune processes. Ongoing research into their pathogenesis offers hope for improved management and new therapies for this chronic skin condition.

Related Experiment Videos

Last Updated: May 24, 2026

Measuring Psoriasis Severity at Home
02:28

Measuring Psoriasis Severity at Home

Published on: March 1, 2024

Area of Science:

  • Dermatology
  • Immunology
  • Rheumatology

Background:

  • Psoriasis affects 2% globally, with severe forms including erythroderma, pustular lesions, and psoriatic arthritis (PsA).
  • Pathogenesis involves genetic, immunologic, and environmental factors, with complex interactions of cytokines, chemokines, and immune cells.
  • Despite recent advances in understanding its immune basis, a complete grasp of psoriasis and PsA pathogenesis remains elusive.

Purpose of the Study:

  • To summarize current basic science and clinical research on psoriasis and psoriatic arthritis.
  • To provide an overview of future research directions in the field.
  • To highlight the integrated role of various molecular factors in the inflammatory processes of psoriasis and PsA.

Main Methods:

  • Thematic review synthesizing existing scientific literature.
  • Analysis of immunological, genetic, and environmental contributions to disease development.
  • Examination of therapeutic options and management strategies.

Main Results:

  • Psoriasis and PsA result from integrated actions of cytokines, chemokines, adhesion molecules, growth factors, neuropeptides, and T cell receptors.
  • Effective management requires diligent skin care and monitoring for comorbidities like arthritis and coronary artery disease.
  • Significant strides in immunobiology have led to improved therapeutic options for patients.

Conclusions:

  • Psoriasis and psoriatic arthritis are complex immune-mediated diseases with significant global impact.
  • Continued research into pathogenesis is crucial for developing more effective treatments.
  • Understanding the intricate interplay of factors driving these conditions is key to advancing patient care.